drugset / Trial / NCT00413764

Efficacy of Tibolone Versus Transdermal E2/NETA on Sexual Function in Naturally Postmenopausal Women (P06089)

NCT00413764

Phase 3 Completed 358 enrolled Organon and Co
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Tibolone has been registered for treatment of menopausal symptoms. It is, however, not known what the effects are of tibolone in postmenopausal women diagnosed with sexual dysfunction. This is important because there is currently no approved treatment of libido problems in postmenopausal women. Therefore, the primary aim of this study was to compare the effects of tibolone with an estrogen/progestogen skin patch in postmenopausal women diagnosed sexual dysfunction.

Timeline

Start
2004-03-23
Primary completion
2005-11-15
Completion
2005-11-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Estradiol Other / unclassified 50 ug Other
Comparator Norethindrone Unknown 140 ug Other
Subject Tibolone Other / unclassified 2.5 mg

Indications